Despite rapid innovation, UK patients wait up to 14 years for new cancer drugs Despite rapid innovation, UK patients wait up to 14 years for new cancer drugs Time from patent to patient has increased by more than a year, Institute of Cancer Research finds in new study 04 Dec 2018 Health
Warwick awarded £2.3M to help develop cutting-edge technologies for cancer diagnosis and personalised treatment 06 Nov 2018 Health
VIB, CD3 and Galapagos NV enter license deal for the development of MALT1 inhibitors VIB, CD3 and Galapagos NV enter license deal for the development of MALT1 inhibitors 10 Jan 2018 Health